Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 8, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Davita Inc.
| 209.45K |
$101.23 | -$21,935,192.15 | +42.36% | 703.93K |
Mar 6
| |||||||
Davita Inc.
| 55.48K |
$96.71 | -$21,936,081.92 | +12.64% | 494.48K |
Feb 26 - Feb 28
| |||||||
Davita Inc.
| 105.7K |
$88.30 | -$8,999,513.60 | +31.71% | 439K |
Dec 14
| |||||||
Davita Inc.
| -41.10K |
$96.86 | -$3,981,236.58 | -10.98% | 333.3K |
May 15
| |||||||
Davita Inc.
| 58.78K |
$83.38 | -$3,015,482.72 | +18.62% | 374.4K |
May 10
| |||||||
Gilead Sciences, Inc.
| 1.89K |
—
|
—
| +29.01% | 8.39K |
May 3
| |||||||
Davita Inc.
| 14.47K |
$81.09 | -$1,095,316.58 | +4.81% | 315.62K |
Jun 6
| |||||||
Davita Inc.
| -53.27K |
$100.05 | -$7,820,008.05 | -15.03% | 301.15K |
May 12 - May 15
| |||||||
Gilead Sciences, Inc.
| 2.44K |
—
|
—
| +60.18% | 6.5K |
May 5
| |||||||
Gilead Sciences, Inc.
| 2.22K |
—
|
—
| +120.95% | 4.06K |
May 3
| |||||||
Davita Inc.
| 109.48K |
—
|
—
| +44.70% | 354.42K |
Apr 22
| |||||||
Gilead Sciences Inc
| 1.84K |
—
|
—
|
∞
| 1.84K |
Jun 15
| |||||||
Davita Inc.
| -28.68K |
$125.41 | -$3,597,009.62 | -10.48% | 244.94K |
May 15
| |||||||
Gilead Sciences Inc
|
0
|
—
|
—
|
—
|
0
|
May 12
| |||||||
Davita Inc.
|
0
|
$99.27 | -$5,918,211.97 |
—
| 273.63K |
May 5
| |||||||
Davita Inc.
| 6.07K |
—
|
—
| +2.27% | 273.63K |
Apr 20
| |||||||
Davita Inc.
| 50.44K |
—
|
—
| +23.23% | 267.55K |
Feb 25
| |||||||
Gilead Sciences Inc
| -189.00 |
$75.50 | -$14,269.50 | -100.00% |
0
|
Jun 23
| |||||||
Gilead Sciences Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Gilead Sciences Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Gilead Sciences Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Davita Inc.
| -611.00 |
$79.25 | -$141,302.75 | -0.28% | 217.12K |
May 15
| |||||||
Davita Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 23
| |||||||
Davita Inc.
| 644 |
$43.42 | -$21,970.52 | +0.30% | 217.73K |
Jun 2
| |||||||
Davita Inc.
| 74.19K |
$50.22 | -$63,628.74 | +51.92% | 217.08K | +1 |
May 15
| ||||||
Davita Inc.
| 2.4K |
—
|
—
| +1.96% | 125.25K | +1 |
Jun 2
| ||||||
Davita Inc.
| 1.29K |
—
|
—
| +1.06% | 122.85K | +1 |
May 15
| ||||||
Davita Inc.
| -18.64K |
$69.45 | -$1,294,270.20 | -13.29% | 121.55K | +1 |
Mar 16
| ||||||
Davita Inc.
| 42.37K |
$64.19 | -$64.60 | +43.32% | 140.19K | +1 |
Mar 16
| ||||||
Davita Inc.
|
0
|
$62.10 | -$1,520,501.72 |
—
| 97.82K | +1 |
Dec 7
| ||||||
Davita Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Davita Inc.
|
0
|
$66.21 | -$85,670.31 |
—
| 97.82K |
May 15
| |||||||
Davita Inc.
| 33.55K |
$50.31 | -$16.02 | +52.21% | 97.82K |
Nov 30
| |||||||
Davita Healthcare Partners Inc.
| -36.47K |
$75.44 | -$2,751,093.50 | -36.20% | 64.26K |
May 13 - May 16
|
Scheduled
| ||||||
Davita Healthcare Partners Inc.
|
0
|
$58.60 | -$6,609,129.50 |
—
| 100.73K |
Apr 11
|
Scheduled
| ||||||
Davita Healthcare Partners Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Jun 2
| ||||||
Davita Healthcare Partners Inc.
| 36.47K |
$81.50 | -$2,972,000.88 | +56.74% | 100.73K | +1 |
May 15
|
Scheduled
| |||||
Davita Healthcare Partners Inc.
|
0
|
$63.79 | -$1,771,410.84 |
—
| 64.26K | +1 |
Apr 27
|
Scheduled
| |||||
Davita Healthcare Partners Inc.
|
0
|
$55.55 | -$222,634.54 |
—
| 64.26K | +1 |
Mar 12
| ||||||
Davita Healthcare Partners Inc.
| -7.00K |
$67.50 | -$472,500.00 | -9.82% | 64.26K | +1 |
May 15
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.